FDA Adverse Event Injury Summary report: N

WATCHMAN TRUSEAL ACCESS SYSTEM

MDR report key: 21105782 · Received January 8, 2025

Report

Report Number
2124215-2024-81171
Event Type
Injury
Date Received
January 8, 2025
Date of Event
December 18, 2024
Report Date
January 8, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
DQY
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

A CARDIAC PERFORATION, A PERICARDIAL EFFUSION (PE) AND CARDIAC TAMPONADE WERE REPORTED. THE PROCEDURE WAS CANCELLED. IT WAS REPORTED THAT A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS BEING PERFORMED. AN NTK KIT WAS SELECTED FOR USE. THE TRANSSEPTAL PUNCTURE WAS PERFORMED WITH NRG RF NEEDLE FROM THE NTK KIT. A WATCHMAN TRUSEAL DOUBLE CURVE ACCESS SYSTEM (WAS) WAS ADVANCED INTO THE LEFT ATRIUM (LA). ON TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) IMAGING, IT WAS NOTED THERE WAS POOR VISIBILITY. WHILE THE WAS AND NON-BOSTON SCIENTIFIC (BSC) GUIDEWIRE WERE IN THE LA, ATTEMPTS TO SECURE ACCESS IN THE PULMONARY VEIN WERE DIFFICULT, AND A PE WAS VISIBLE IN TEE BEHIND THE LAA. EMERGENCY MANAGEMENT OF THE EVENT WAS INITIATED, AND IT WAS NOTED THERE WAS A CARDIAC PERFORATION IN THE LAA, BLOOD LOSS/HEMORRHAGE, AND CARDIAC TAMPONADE. PERICARDIOCENTESIS WAS PERFORMED. THE PROCEDURE WAS CANCELLED. HEART SURGERY WAS PERFORMED IN RESPONSE TO THE LAA CARDIAC PERFORATION. BLOOD TRANSFUSION WAS ADMINISTERED. PATIENT OUTCOME REMAINS UNKNOWN. IN THE PHYSICIAN'S OPINION, THE NON-BSC GUIDEWIRE MAY HAVE CAUSED THE PERFORATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1554363 WATCHMAN TRUSEAL ACCESS SYSTEM SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL DQY BOSTON SCIENTIFIC CORPORATION 0033981158

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention